Welcome to LookChem.com Sign In|Join Free

CAS

  • or

203664-68-0

Acetic acid, [(5-amino-2-pyridinyl)oxy]-, ethyl ester (9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

203664-68-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 203664-68-0 Structure

  • Basic information

    1. Product Name: Acetic acid, [(5-amino-2-pyridinyl)oxy]-, ethyl ester (9CI)
    2. Synonyms: Acetic acid, [(5-amino-2-pyridinyl)oxy]-, ethyl ester (9CI)
    3. CAS NO:203664-68-0
    4. Molecular Formula: C9H12N2O3
    5. Molecular Weight: 196.20318
    6. EINECS: N/A
    7. Product Categories: PYRIDINE
    8. Mol File: 203664-68-0.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: Acetic acid, [(5-amino-2-pyridinyl)oxy]-, ethyl ester (9CI)(CAS DataBase Reference)
    10. NIST Chemistry Reference: Acetic acid, [(5-amino-2-pyridinyl)oxy]-, ethyl ester (9CI)(203664-68-0)
    11. EPA Substance Registry System: Acetic acid, [(5-amino-2-pyridinyl)oxy]-, ethyl ester (9CI)(203664-68-0)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 203664-68-0(Hazardous Substances Data)

203664-68-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 203664-68-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,3,6,6 and 4 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 203664-68:
(8*2)+(7*0)+(6*3)+(5*6)+(4*6)+(3*4)+(2*6)+(1*8)=120
120 % 10 = 0
So 203664-68-0 is a valid CAS Registry Number.

203664-68-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 2-(5-aminopyridin-2-yloxy)acetate

1.2 Other means of identification

Product number -
Other names ethyl 5-aminopyridyl-2-oxyacetate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:203664-68-0 SDS

203664-68-0Relevant articles and documents

An Orally Bioavailable, Indole-3-glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer

Colley, Helen E.,Muthana, Munitta,Danson, Sarah J.,Jackson, Lucinda V.,Brett, Matthew L.,Harrison, Joanne,Coole, Sean F.,Mason, Daniel P.,Jennings, Luke R.,Wong, Melanie,Tulasi, Vamshi,Norman, Dennis,Lockey, Peter M.,Williams, Lynne,Dossetter, Alexander G.,Griffen, Edward J.,Thompson, Mark J.

, p. 9309 - 9333 (2015/12/23)

A number of indole-3-glyoxylamides have previously been reported as tubulin polymerization inhibitors, although none has yet been successfully developed clinically. We report here a new series of related compounds, modified according to a strategy of redu

Microsomal triglyceride transfer protein inhibitor

-

Page/Page column 27, (2010/02/07)

The present invention provides inhibitors of microsomal triglyceride transfer protein (MTP) and/or apolipoprotein B (Apo B) secretion having Formula (I) which are useful for the treatment of obesity and related diseases, as well as prevention and treatment of atherosclerosis and its clinical sequelae, for lowering serum lipids, and in the prevention and treatment of related diseases. The invention further relates to pharmaceutical compositions comprising the compounds of the present invention and to methods of treating obesity, atherosclerosis, and related diseases and/or conditions with the compounds of the present invention, either alone or in combination with other medicaments, including lipid-lowering agents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 203664-68-0